Sign in
4/A

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-13-019552

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

McKenney Charles · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2013-03-21 Grant or award : show line 1 in the form Stock Option +15,000 68,000 D
Loading xslF345X03/rrd375640.xml…